Catechin clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How each study uses Catechin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
12 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 11
Craig McDonald, MD (3) · National Polytechnic Institute, Mexico (1) · University Ghent (1) · University of Reading (1) · Veterans Medical Research Foundation (1) · Brooklyn College of the City University of New York (1) · Danisco (1) · Wageningen University (1)
Often tested with
Tested in the same studies.
Proanthocyanidins (1) · Quercetin (1) · Ascorbic Acid (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
- One of Flavonoids source
Studies
Open first, then newest update. How each study uses Catechin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Effects of COcoa Supplement in OBese Adolescent SubjectsCompletedNot applicableNational Polytechnic Institute, MexicoNCT04112251Written as Cocoa Flavonols SupplementHow we know
- The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-olsCompletedNot applicableUniversity GhentNCT05113498Written as (-)-EpicatechinHow we know
- Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)CompletedPhase 1/2Craig McDonald, MDNCT01856868Written as (-)-epicatechinHow we know
- Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory AdolescentsCompletedPhase 1/2Craig McDonald, MDNCT02964377Written as (+)- EpicatechinHow we know
- (-)- Epicatechin Becker Muscular DystrophyCompletedPhase 2Craig McDonald, MDNCT03236662Written as (-)-EpicatechinHow we know
- Cross-over Double-blind Intervention to Investigate the Effects of Defined Antioxidant-containing Drinks on Time Course of Antioxidant CapacityStatus unknownNot applicableNewcastle UniversityNCT02898571Written as epicatechinHow we know
- An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy MenCompletedEarly Phase 1University of ReadingNCT02292342Written as Epicatechin 0.1 mg/kgHow we know
- Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)CompletedPhase 1Veterans Medical Research FoundationNCT02656212Written as epicatechinHow we know
- The Randomized Controlled Cocoa-Appetite TrialCompletedNot applicableBrooklyn College of the City University of New YorkNCT02408289Written as EpicatechinHow we know
- (-)-Epicatechin and Pulmonary Arterial HypertensionWithdrawnPhase 1University of California, San FranciscoNCT01880866Written as (-)-EpicatechinHow we know
- Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory FunctionCompletedPhase 2DaniscoNCT01690676Written as EpicatechinHow we know
- Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)CompletedNot applicableWageningen UniversityNCT01691404Written as EpicatechinHow we know
Codes
What other systems call Catechin · ClinicalTrials.gg INT007163
- MeSH (NLM) D002392CatechinOne source NLM
- UNII (FDA) 34PHS7TU43EPICATECHINConfirmed FDA, NLM, Wikidata
- Wikidata Q23050136(−)-epicatechinConfirmed FDA, NLM, Wikidata
- Wikidata Q415007(+)-catechinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221986EpicatechinOne source FDA
- DrugBank DB12039One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002392 | Catechin | One source NLM |
| UNII (FDA) | 34PHS7TU43 | EPICATECHIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q23050136 | (−)-epicatechin | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q415007 | (+)-catechin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221986 | Epicatechin | One source FDA |
| DrugBank | DB12039 | — | One source Wikidata |
Also registered as cianidanol (UNII 8R1V1STN48 · RxNorm 1367177).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.